English
-
Grand Journey for A Healthier World
Grand Pharma Announces 2022 Interim Results
The Group recorded revenue of HKD5.21 billion, representing an increase of 14.1% YoY.
Statement on Recent Fraudulent Use of the Commercial Name of Grand Pharma to Conduct Internet Financial Fraud
